These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12235096)

  • 1. Reducing dyspepsia costs in the community.
    Duggan A; Westbrook J
    Gut; 2002 Oct; 51(4):613; author reply 613. PubMed ID: 12235096
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic patients.
    Vaira D
    Intern Emerg Med; 2015 Oct; 10(7):763-4. PubMed ID: 26350279
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
    BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
    Vakil N
    Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A
    Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.
    Said Essa A; Alaa Eldeen Nouh M; Mohammed Ghaniam N; Graham DY; Said Sabry H
    Scand J Infect Dis; 2008; 40(9):730-3. PubMed ID: 19086246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
    Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2008 May; 103(5):1106-13. PubMed ID: 18445098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease.
    Owen RJ; Peters TM; Varea R; Teare EL; Saverymuttu S
    FEMS Immunol Med Microbiol; 2001 Feb; 30(1):65-71. PubMed ID: 11172993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya.
    Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA
    Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients.
    Dore MP; Marras G; Rocchi C; Soro S; Loria MF; Bassotti G; Graham DY; Malaty HM; Pes GM
    Intern Emerg Med; 2015 Oct; 10(7):787-94. PubMed ID: 25739590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing prevalence of some selected gastrointestinal diseases vis-à-vis H. pylori infection.
    Fixa B; Komárková O; Nozicka Z
    Hepatogastroenterology; 2011; 58(107-108):1062-6. PubMed ID: 21830443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.
    Briggs AH; Sculpher MJ; Logan RP; Aldous J; Ramsay ME; Baron JH
    BMJ; 1996 May; 312(7042):1321-5. PubMed ID: 8646042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of outpatients with dyspepsia.
    Millard P; Fitzpatrick BP
    J Fam Pract; 1997 Sep; 45(3):199-200. PubMed ID: 9312557
    [No Abstract]   [Full Text] [Related]  

  • 18. Protagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia?
    McColl KE
    Gut; 2001 Jun; 48(6):759-61. PubMed ID: 11358891
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Ford AC; Forman D; Nathan J; Crocombe WD; Axon AT; Moayyedi P
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1267-75. PubMed ID: 17944741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India.
    Katelaris PH; Tippett GH; Norbu P; Lowe DG; Brennan R; Farthing MJ
    Gut; 1992 Nov; 33(11):1462-6. PubMed ID: 1452068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.